¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"mutation disturbance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • chromosome mutation
    ¿°»öüµ¹¿¬º¯ÀÌ
  • drift mutation
    ¿¬¼Óº¯ÀÌ
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • forward mutation
    ¾ÕÂʵ¹¿¬º¯ÀÌ, ÀüÇâµ¹¿¬º¯ÀÌ
  • frameshift mutation
    ƲÀ̵¿µ¹¿¬º¯ÀÌ
  • genetic mutation
    À¯Àüµ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯Àüüµ¹¿¬º¯ÀÌ
  • induced mutation
    À¯¹ßµ¹¿¬º¯ÀÌ
  • loss-of-function mutation
    ±â´É¼Ò½Çµ¹¿¬º¯ÀÌ
  • missense mutation
    °ú¿Àµ¹¿¬º¯ÀÌ, ¹Ì½º¼¾½ºµ¹¿¬º¯ÀÌ
  • mutation
    µ¹¿¬º¯ÀÌ
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ
  • mutation rate
    µ¹¿¬º¯ÀÌÀ²
  • natural mutation
    ÀÚ¿¬µ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • back mutation
    ¿ªµ¹¿¬º¯ÀÌ, º¹±Íµ¹¿¬º¯ÀÌ
  • chromosomal mutation
    ¿°»öüº¯ÀÌ, ¿°»öüµ¹¿¬º¯ÀÌ
  • cold-sensitive mutation
    Àú¿Â¹Î°¨µ¹¿¬º¯ÀÌ
  • conditional mutation
    Á¶°Çµ¹¿¬º¯ÀÌ
  • conditional lethal mutation
    Á¶°ÇÄ¡»çµ¹¿¬º¯ÀÌ
  • dominant mutation
    ¿ì¼ºµ¹¿¬º¯ÀÌ
  • drift mutation
    ¿¬¼Óº¯ÀÌ
  • mutation detection
    µ¹¿¬º¯À̰ËÃâ
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • forward mutation
    ÀüÇâµ¹¿¬º¯ÀÌ
  • frequency mutation
    µ¹¿¬º¯À̺óµµ
  • genetic mutation
    À¯Àüµ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ, À¯Àüüµ¹¿¬º¯ÀÌ
  • mutation genetics
    º¯ÀÌÀ¯ÀüÇÐ
  • host range mutation
    ¼÷ÁÖ¹üÀ§º¯ÀÌ, ¼÷ÁÖ¿ªº¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • electolyte disturbance
    ÀüÇØÁúÀåÇØ(ï³ú°òõî¡úª).
  • electrolyte disturbance
    ÀüÇØÁúÀå¾Ö(¡­î¡äô).
  • emotional disturbance
    °¨Á¤ÀåÇØ
  • expressive disturbance
    Ç¥Çö¼º Àå¾Ö.
  • extrapyramidal motor disturbance
    Ãßü¿Ü·Î¿îµ¿Àå¾Ö.
  • frameshift mutation
    ÇØµ¶Æ² µ¹¿¬º¯ÀÌ, ÇÁ·¹ÀÓ½¬ÇÁÆ® µ¹¿¬º¯ÀÌ
  • frequency, mutation
    µ¹¿¬º¯À̺óµµ
  • gene mutation
    ÇØºÎ
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ(ÔÍæÔܨì¶).
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
  • gene mutation
    À¯ÀüÀÚ(µ¹¿¬)º¯ÀÌ
  • genetic mutation
    À¯ÀüÀû µ¹¿¬º¯ÀÌ
  • genomic mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ
  • hearing disturbance
    û·ÂÀå¾Ö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • polarity mutation
    ±Ø¼º º¯ÀÌ(пàõܨì¶)
  • polar mutation
    ±Ø¼º º¯ÀÌ(пàõܨì¶)
  • promoter-down mutation
    ÇÁ·Î¸ðÅÍ ±â´ÉÀúÇÏ º¯ÀÌ(ѦÒöî¸ù»Ü¨ì¶)
  • promoter mutation
    ÇÁ·Î¸ðÅÍ º¯ÀÌ(ܨì¶)
  • promoter-up mutation
    ÇÁ·Î¸ðÅÍ ±â´É»ó½Âº¯ÀÌ(ѦÒöß¾ã°Ü¨ì¶)
  • Quaking mutation
    ÄùÀÌÅ· º¯ÀÌ(ܨì¶).
  • samesense mutation
    µ¿ÀÇ º¯ÀÌ(ÔÒëòܨì¶)
  • second-site mutation
    µÑ° ÀÚ¸® º¯ÀÌ(ܨì¶)
  • semilethal mutation
    ÁØÄ¡»ç º¯ÀÌ(ñÞöÈÞÝܨì¶)
  • sign mutation
    ½ÅÈ£º¯ÀÌ(ãáûÜܨì¶)
  • silent mutation
    ħ¹¬ º¯ÀÌ(öØÙùܨì¶)
  • single-site mutation
    ¿ÜÀÚ¸® º¯ÀÌ(ܨì¶)
  • somatic mutation
    ü¼¼Æ÷ º¯ÀÌ(ô÷á¬øàܨì¶)
  • somatic mutation theory
    ü¼¼Æ÷ º¯ÀÌÀÌ·Ð(ô÷á¬øàܨì¶×âÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
RDI recommended daily intake; respiratory disturbance index; rupture-delivery interval
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 3
Tfm testicular feminization mutation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • electrolyte disturbance
    ÀüÇØÁú Àå¾Ö
  • epithelial disturbance
    »óÇÇ Àå¾Ö
  • extrapyramidal motor disturbance
    Ãßü¿Ü ¿îµ¿Àå¾Ö
  • functional temporomandibular joint disturbance
    ±â´ÉÀû ÃøµÎÇϾǰüÀý Àå¾Ö
  • hearing disturbance
    û·Â Àå¾Ö
    À½À» Á¦´ë·Î ´À³¢Áö ¸øÇÏ´Â »óÅÂ.
  • hemodynamic disturbance
    Ç÷Çà ¿ªÇÐÀû Àå¾Ö
  • hereditary disturbance
    À¯Àü¼º Àå¾Ö
    ¼±ÃµÀûÀ¸·Î ¾î¹öÀ̷κÎÅÍ ÀÚ¼Õ¿¡°Ô ¹°·ÁÁ® ³»¸®´Â Áúº´.
  • labyrinthine disturbance
    ¹Ì·Î Àå¾Ö
  • language disturbance
    ¾ð¾î Àå¾Ö
    µ¿ÀǾî=language disorder.
  • motility disturbance
    ¿îµ¿ Àå¾Ö
  • motor disturbance
    ¿îµ¿ Àå¾Ö
    ¸öÀÇ ¼öÀÇÀû ¿îµ¿, ¿¹¸¦ µé¸é »çÁö, ¸öÅë, ¸ñ, ¾ó±¼, ¾È±¸, Çô µîÀ» ¿òÁ÷ÀÌ´Â ¿îµ¿ÀÌ ÀÚÀÇ·Î Àß ¾È µÇ´Â »óÅÂ. Àå¾Ö¸¦ ÀÏÀ¸Å°´Â ÇØºÎÇÐÀû º´º¯¿¡ µû¶ó Ãßü·Î°èÀÇ ¿îµ¿ Àå¾Ö, ¼Ò³ú°èÀÇ ¿îµ¿ Àå¾Ö, Ãßü¿Ü·Î°èÀÇ ¿îµ¿ Àå¾Ö, ¸»ÃʽŰæ°èÀÇ ¿îµ¿ Àå¾Ö·Î ³ª´­ ¼ö ÀÖ´Ù.¡¼Ãßü·Î°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü·Î´Â ´ë³ú ÇÇÁú¿îµ¿¾ß ÁÖÀ§ÀÇ ±¤¹üÀ§ÇÑ ÇÇÁú ³»¿¡ ÀÖ´Â ¸¹Àº ½Å°æ ¼¼Æ÷µé·ÎºÎÅÍ ½Å°æ ¼¶À¯°¡ ³ª¿Í ¸ð¿©¼­ ³ú°£, ¿¬¼ö¸¦ °ÅÃÄ Ã´¼öÀÇ È¸¹éÁú¿¡ ÀÖ´Â ¿îµ¿ ½Å°æ ¼¼Æ÷¿Í ¿¬Á¢µÉ ¶§±îÁöÀÇ ½Å°æ ¼¶À¯ÀÇ ´Ù¹ßÀ̸ç, ÀÌ °æ·Î¿¡ º´º¯ÀÌ ÀÖÀ» ¶§ ¼öÀÇ ¿îµ¿ Àå¾Ö°¡ ³ªÅ¸³ª´Âµ¥, ƯÈ÷ »çÁöÀÇ ¸»´ÜºÎ¿¡¼­ ½ÉÇÏ´Ù. Áï, ¼¼¹ÐÇϰí Á¤±³ÇÑ ¼Õ°¡¶ôÀÇ ¿òÁ÷ÀÓ µîÀÌ Àß ¾È µÇ°í ½Ã°£ÀÌ °¨¿¡ µû¶ó Àå¾Ö ±ÙÀ°Àº °­Á÷ÇØÁø´Ù.¡¼¼Ò³ú°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü·Î´Â ¿îµ¿ ±â´ÉÀÇ Á¶Á¤ ¹× ÅëÇÕÀÇ ¿ªÇÒ°ú ±Ù ±äÀåÀ» Á¶ÀýÇÏ°í ¸öÀÇ ÆòÇüÀ» À¯ÁöÇÏ´Â µ¥ °ü¿©ÇÑ´Ù. À̰÷¿¡ º´º¯ÀÌ ÀÖÀ¸¸é Á¤±³ÇÑ ¼öÀǿ¿¡ Àå¾Ö°¡ ¿À°í, ±Ù ±äÀå ÀúÇÏ, ±âµµ ÁøÀü, ºÒ¸í·á ¾ð¾î, ¿îµ¿½ÇÁ¶Áõ µîÀÌ ³ªÅ¸³ª¸ç, ÆòÇü ±â´É Àå¾Ö·Î ¶È¹Ù·Î ¼­Áö ¸øÇϰí ÀÚ²Ù ¾²·¯Áö·Á°í ÇÏ¸ç ¼ú ÃëÇÑ »ç¶÷ó·³ °È´Â´Ù.¡¼Ãßü¿Ü·Î°èÀÇ ¿îµ¿ Àå¾Ö¡½ Ãßü¿Ü·Î´Â ¼±»óü, ´ãⱸ·Î ±¸¼ºµÈ ´ë³ú ±âÀú ÇÙ°ú ´ë³ú ÇÇÁú, ½Ã»ó, Áß³ú, ½Ã»ó ÇÏÇÙ, ÈæÁúÀÌ ¹«¼öÇÑ ½Å°æ¼¶À¯·Î ¼­·Î ¿¬°áµÇ¾î ÀÖ¾î, ¼öÀǿÀ» ¼öÇàÇÏ´Â µ¥ ÇÊ¿äÇÑ ÀÚ¼¼ À¯Áö¿Í ¼öÀǿÀ» °è¼Ó °ß½ÇÇÏ°Ô ÇÏ´Â ¿ªÇÒÀ» ÇÑ´Ù. ¼±»óü¿¡ º´º¯ÀÌ ÀÖÀ¸¸é ¿©·¯ ÇüÅÂÀÇ ºñÁ¤»ó ºÒ¼öÀǿÀÌ ³ªÅ¸³ª¸ç ±Ù ±äÀåÀÇ Àå¾Öµµ ¿Â´Ù. ºñÁ¤»ó ºÒ¼öÀǿÀ¸·Î´Â ¼Õ, ¸Ó¸®, ÀÔ¼ú µî¿¡ Á¤Áö½Ã ÁøÀü, ¾ÆÅ×Åä½Ã½º
  • neurogenic disturbance
    ½Å°æ¼º Àå¾Ö
  • occlusomandibular disturbance
    ±³ÇÕ ÇÏ¾Ç Àå¾Ö
  • progressive focal neurologic disturbance
    ÁøÇ༺ ±¹¼ÒÀû ½Å°æÇÐÀû Àå¾Ö
  • psychomotor disturbance
    Á¤½Å ¿îµ¿ Àå¾Ö
    Á¤½Å Áúȯ¿¡¼­ º¼ ¼ö ÀÖ´Â Á¤½Å ÀåÇØ¸¦ ³ªÅ¸³»´Â Çൿ ¹× ¿îµ¿ ÀåÇØ·Î ÀÇÁö ¿îµ¿ÀÇ ÀåÇØ¶ó ÇÒ ¼ö ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
nonsense mutation <molecular biology> A mutation that causes a polypeptide chain to be ended prematurely.
(13 Nov 1997)
null mutation Change in a gene that leads to nothing, for example to no enzyme or to a nonfunctioning enzyme.
(12 Dec 1998)
suppressor mutation <molecular biology> Mutation that alleviates the effect of a primary mutation at a different locus.
May be through almost any mechanism that can give a primary mutation, but perhaps the most interesting class are the amber and ochre supressors, where the anticodon of the tRNA is altered so that it mis reads the termination codon and inserts an amino acid, preventing premature termination of the peptide chain.
(18 Nov 1997)
deletion mutation <molecular biology> A mutation in which one or more (sequential) nucleotides is lost by the genome. If the number lost is not divisible by 3 and is in a coding region, the result is a frameshift mutation.
(18 Nov 1997)
down promoter mutation <molecular biology> A mutation (a change in base pair sequence) in a promoter region, this results in lower gene expression (less transcription of the gene occurs).
(09 Oct 1997)
induced mutation A mutation caused by exposure to a mutagen.
(05 Mar 2000)
insertion mutation A mutation caused by the insertion of at least one extra nucleotide basein a DNA sequence.
(09 Oct 1997)
ochre mutation Mutation that changes any codon to the termination codon UAA.
(18 Nov 1997)
opal mutation <molecular biology> Mutation that changes any codon to the termination codon UGA.
(18 Nov 1997)
temperature sensitive mutation <genetics, molecular biology> A type of conditional mutation in organism, somatic cell or virus that makes it possible to study genes whose total inactivation would be lethal. Such ts mutations can also make possible studies of the effect of reversible switching by temperature changes) in expression of the mutated gene. The usual mechanism of temperature sensitivity is that the mutated gene codes for a protein with a temperature dependent conformational instability, so that it possesses normal activity at one temperature (the permissive temperature), but is inactive at a second (nonpermissive) temperature.
(18 Nov 1997)
transition mutation A point mutation involving substitution of one base-pair for another, i.e., replacement of one purine for another and of one pyrimidine for another pyrimidine without change in the purine-pyrimidine orientation.
(05 Mar 2000)
transversion mutation A point mutation involving base substitution in which the orientation of purine and pyrimidine is reversed, in contradistinction to transition mutation.
(05 Mar 2000)
umber mutation A mutation yielding the termination codon UGA, resulting in premature termination of a polypeptide chain.
Compare: suppressor mutation.
Synonym: opal mutation.
(05 Mar 2000)
unstable mutation <molecular biology> A mutation that has a high likelihood of reverting to its original form.
(13 Nov 1997)
up mutation <molecular biology> Refers to any mutation in the promoter region of a gene which can trigger transcription initiation.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á